Create Self-Destructing Website That Vanishes If You Don't Post for 30 Days

To delete your Google Drive files, move them to the trash. Files in trash will be automatically deleted after 30 days. You can restore files from your trash before the 30-day time window. You can also permanently delete them to empty your trash. If you delete, restore, or permanently delete multiple files or folders at once, it might take time for you to notice the changes.

In the term of an active subscription, a subscriber can access, extract, or delete customer data stored in Microsoft 365. If a paid subscription ends or is terminated, Microsoft retains customer data stored in Microsoft 365 in a limited-function account for 90 days to enable the subscriber to extract the data. After the 90-day retention period ends, Microsoft disables the account and deletes the customer data. No more than 180 days after expiration or termination of a subscription to Microsoft 365, Microsoft disables the account and deletes all customer data from the account. Once the maximum retention period for any data has elapsed, the data is rendered commercially unrecoverable.

Create Self-Destructing Website That Deletes Automatically After 30 Days of No Posting

Download

Your closure of your AWS account serves as a notice to us that you want to terminate theAWS service customer agreement or other agreements with AWS services that governs your AWS account, solely with respect to the specific AWS account. If you reopen your AWS account during the post-closure period (that is, within 90 daysafter your account is closed), you agree that the same agreement terms will governyour access to and use of the service offerings through your reopenedAWS account.

If you've turned on multi-factor authentication (MFA) on your AWS account root user, or configured an MFA device on an IAM user, the MFA isn't removed automatically when you close the account. If you choose to leave the MFA turned on during the 90 days post-closure period, keep the virtual hardware MFA device active until the post-closure period expired in case you need to access the account during that time.

When you close an account that was created with AWS Organizations, that account isn't removed fromthe organization until after the post-closure period. During the post-closureperiod, a closed member account still counts toward your quota of accounts in theorganization.

Yahoo 99 (Eric) wrote that they created this demo app because they were frustrated with the trade-offs that are built in to practically every website, and every social media network. You give a webpage your personal information, you give it to the webpage every time you return, and you wait for your data to be sold or hacked.

I was looking into the possibility of making a small jobsite with wordpress. That is the reason why I would like to automatically delete posts after some time. But a redirection to a page that states that this job is no longer online would be very appropriate. Hope this helps.

If you have fewer than 30 projects remaining in your quota, a notificationdisplays the number of projects remaining in your quota on theNew Project page. Once you have reached yourproject limit, to create more projects you must request a project limitincrease. Alternatively, you can schedule some projects to be deleted after 30days on theManage Resources Page.Projects that users havesoft deleted count against your quota. These projectsfully delete after 30 days.

The system will automatically delete closed, unlocked, and non-migrated questions that have zero or negative score, have no positively scored or accepted answers or pending reopen votes, were closed for any reason other than duplicate nine or more days ago, and haven't been edited in the past nine days. (RemoveAbandonedClosed)

The system will automatically delete negatively-scored, non-migrated, unlocked, and unanswered questions (both open and closed, including as duplicates) that are older than 30 days. (RemoveDeadQuestions)

The system will automatically delete unlocked, unanswered questions older than 365 days on main (non-meta) sites, that have a score of zero (or have a score of 1 and the owner's account is deleted), have fewer than 1.5 views per day on average, and fewer than two comments. (RemoveAbandonedQuestions)

The system will automatically delete migration stubs (original site copies of questions migrated to other sites, which haven't been rejected by the destination site) that are at least 30 days old. Questions deleted under this criterion still have their revision histories visible to everyone, and links to them redirect to the new question instead of showing an error page. (RemoveMigrationStubs)

Starting today, you can enable an auto-delete timer in all Telegram chats, which will automatically erase messages for all participants either 24 hours or 7 days after sending.

The study might also be undergoing review. After the Responsible Party Releases (submits) information to ClinicalTrials.gov, that information undergoes a manual review to identify possible errors, deficiencies, or inconsistencies that are not detected automatically during data entry. The Responsible Party will be notified of any issues that need correction, usually within a few days after release of the protocol information. The review of results information may take longer (up to 30 days).

If a sponsor of a clinical trial in a foreign country that does not meet the definition of an ACT, and has an initiation date after the effective date of the regulations in 42 CFR Part 11, decides to add a location in the U.S. (or its territories), and as a result the trial meets the definition of an ACT, the sponsor becomes subject to section 402(j) of the Public Health Service Act and 42 CFR Part 11. The requirements set forth in the regulation would need to be met, beginning with registration of the ACT not later than 21 days after the enrollment of the first participant at the U.S. site. Per 42 CFR 11.22(b), "[a] clinical trial or study that, at any point in time, meets the conditions listed in paragraph (b)(1) or (2) of this section will be considered to meet the definition of an applicable clinical trial." Therefore, this trial would become an ACT when it adds the U.S. site. Clinical trial registration information must include information applicable to the entire trial, as is the case with all multi-site trials with information in ClinicalTrials.gov, because the entire clinical investigation is considered to be the applicable device or drug clinical trial (see 81 FR 65013, 81 FR 65015).

For an applicable device clinical trial that is a pediatric postmarket surveillance of a device product and is not a clinical trial, the registration information specified in section 402(j)(2)(A)(ii) of the PHS Act or 42 CFR 11.28(b) must be submitted within 21 days after FDA approves the postmarket surveillance plan.

In the second scenario, there is only one informed consent document for both trial screening and trial participation. In this scenario, the Final Rule preamble explains that a participant would not be considered enrolled until he or she met all the eligibility criteria assessed during screening, unless the participant is considered enrolled as outlined specifically in the protocol. (81 FR 65022) The Final Rule preamble further explains that when there is only one informed consent document for both trial screening and trial participation, registration information must be submitted as described in 42 CFR 11.24 no later than 21 calendar days after the first participant signs the informed consent form and begins trial participation, in accordance with the protocol.

• Section 801 of the Food and Drug Administration Amendments Act of 2007 (FDAAA 801) requires submission of results information for applicable clinical trials (ACTs) that were initiated after September 27, 2007, or that were ongoing as of December 26, 2007, if the product studied in the ACT is approved, licensed, or cleared by the Food and Drug Administration (FDA) at any time, including after the ACT's primary completion date. For ACTs subject to FDAAA's registration and results submission requirements that have a primary completion date before January 18, 2017 (the effective date of the Final Rule), results information must be submitted as follows:If the ACT studied a drug, biological, or device product that was approved, licensed, or cleared by FDA before the ACT's primary completion date, the responsible party generally must submit the results information specified in section 402(j)(3)(C) and section 402(j)(3)(I) of the Public Health Service (PHS) Act no later than 1 year after the study's primary completion date; however, results information submission for these ACTs may be delayed under certain conditions as specified in section 402(j)(3)(E)(v) (seeking approval, licensing, or clearance of a new use for the drug, biological, or device product) and section 402(j)(3)(E)(vi) (requesting an extension for good cause) of the PHS Act.

• Pursuant to the Federal Court decision in Seife et al. v. HHS et al., 18-cv-11462 (NRB) (S.D.N.Y. Feb. 24, 2020), if the ACT studied a drug, biological, or device product that was not approved, licensed, or cleared for any use as of the primary completion date but is subsequently approved, licensed, or cleared by FDA on or after the ACT's primary completion date, the responsible party must submit the results information specified in section 402(j)(3)(C) and section 402(j)(3)(I) of the PHS Act within 30 days after approval, licensure, or clearance of the drug, biological, or device product, in accordance with section 402(j)(3)(E)(iv) of the PHS Act (seeking initial approval, licensure, or clearance of the drug, biological, or device product) and may be delayed under certain conditions as specified in section 402(j)(3)(E)(vi) (requesting an extension for good cause) of the PHS Act.

If the results submission deadline has already passed for an ACT affected by the Federal Court decision in Seife et al. v. HHS et al., 18-cv-11462 (NRB) (S.D.N.Y. Feb. 24, 2020), what is the deadline for submitting results information? 2ff7e9595c